Labcorp Debt to Equity Ratio 2010-2024 | LH

Current and historical debt to equity ratio values for Labcorp (LH) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Labcorp debt/equity for the three months ending September 30, 2024 was 0.66.
Labcorp Debt/Equity Ratio Historical Data
Date Long Term Debt Shareholder's Equity Debt to Equity Ratio
2024-09-30 $10.44B $8.17B 1.28
2024-06-30 $8.71B $8.01B 1.09
2024-03-31 $8.57B $7.96B 1.08
2023-12-31 $8.85B $7.88B 1.12
2023-09-30 $9.01B $7.87B 1.15
2023-06-30 $8.93B $8.79B 1.02
2023-03-31 $9.86B $10.34B 0.95
2022-12-31 $10.06B $10.10B 1.00
2022-09-30 $9.73B $10.09B 0.96
2022-06-30 $10.00B $10.40B 0.96
2022-03-31 $10.01B $10.72B 0.93
2021-12-31 $10.11B $10.27B 0.98
2021-09-30 $10.34B $10.53B 0.98
2021-06-30 $10.17B $10.25B 0.99
2021-03-31 $10.40B $10.02B 1.04
2020-12-31 $10.64B $9.44B 1.13
2020-09-30 $10.50B $8.24B 1.27
2020-06-30 $10.50B $7.35B 1.43
2020-03-31 $10.28B $7.02B 1.46
2019-12-31 $10.48B $7.57B 1.39
2019-09-30 $10.62B $7.23B 1.47
2019-06-30 $10.60B $7.14B 1.48
2019-03-31 $9.86B $7.11B 1.39
2018-12-31 $9.21B $6.97B 1.32
2018-09-30 $9.41B $7.25B 1.30
2018-06-30 $9.47B $7.04B 1.35
2018-03-31 $9.85B $6.98B 1.41
2017-12-31 $9.87B $6.80B 1.45
2017-09-30 $10.57B $6.13B 1.73
2017-06-30 $9.02B $5.88B 1.54
2017-03-31 $8.78B $5.65B 1.55
2016-12-31 $8.74B $5.51B 1.59
2016-09-30 $8.96B $5.52B 1.62
2016-06-30 $8.89B $5.31B 1.67
2016-03-31 $9.24B $5.17B 1.79
2015-12-31 $9.16B $4.95B 1.85
2015-09-30 $9.51B $4.91B 1.94
2015-06-30 $9.70B $4.77B 2.03
2015-03-31 $9.63B $4.52B 2.13
2014-12-31 $4.48B $2.82B 1.59
2014-09-30 $4.46B $2.77B 1.61
2014-06-30 $4.49B $2.66B 1.69
2014-03-31 $4.49B $2.50B 1.80
2013-12-31 $4.48B $2.49B 1.80
2013-09-30 $4.12B $2.57B 1.61
2013-06-30 $3.93B $2.66B 1.48
2013-03-31 $3.79B $2.78B 1.37
2012-12-31 $4.08B $2.72B 1.50
2012-09-30 $4.10B $2.72B 1.51
2012-06-30 $3.47B $2.63B 1.32
2012-03-31 $3.53B $2.60B 1.36
2011-12-31 $3.61B $2.50B 1.44
2011-09-30 $3.51B $2.54B 1.38
2011-06-30 $3.59B $2.58B 1.39
2011-03-31 $3.80B $2.40B 1.58
2010-12-31 $3.72B $2.47B 1.51
2010-09-30 $2.78B $2.27B 1.22
2010-06-30 $2.75B $2.21B 1.25
2010-03-31 $2.78B $2.16B 1.29
2009-12-31 $2.73B $2.11B 1.30
2009-09-30 $2.80B $2.03B 1.38
2009-06-30 $2.70B $2.01B 1.35
2009-03-31 $3.01B $1.82B 1.66
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $19.758B $12.162B
Laboratory Corporation of America Holdings or LabCorp is a leading healthcare diagnostics company, providing comprehensive clinical laboratory services and end-to-end drug development support. The provide vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $78.151B 21.33
Becton Dickinson (BDX) United States $64.352B 16.92
Cardinal Health (CAH) United States $28.637B 15.53
West Pharmaceutical Services (WST) United States $22.024B 44.99
Cooper (COO) United States $19.726B 28.08
Align Technology (ALGN) United States $16.616B 31.80
Henry Schein (HSIC) United States $9.331B 17.78
Merit Medical Systems (MMSI) United States $6.102B 31.16
DENTSPLY SIRONA (XRAY) United States $3.753B 10.20
CONMED (CNMD) United States $2.216B 18.49
Patterson (PDCO) United States $1.799B 9.49
STAAR Surgical (STAA) United States $1.288B 47.53
Lifevantage (LFVN) United States $0.170B 22.60
Pro-Dex (PDEX) United States $0.147B 29.36